<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2020 Workiva--><!--r:77aefc0f-584c-4e2d-b1a5-083c7d3f7c9d,g:d8625cef-62d5-4108-b169-493c46af3eb5,d:3b46eabfca754a9a9d85cb2631f02e98--><html xmlns:dei="http://xbrl.sec.gov/dei/2019-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cnce-20201210</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF80L2ZyYWc6YmVkNjBlNDI1OTJhNDlhYWExNzk5ODBiMWExYmUzMTMvdGFibGU6NWFjMTFkOThhOGE4NGE5NDg2NWM4YWY1M2E5Y2ZiNGEvdGFibGVyYW5nZTo1YWMxMWQ5OGE4YTg0YTk0ODY1YzhhZjUzYTljZmI0YV8xLTEtMS0xLTA_57a683b2-599e-4f78-bb30-ecedfc7e14c0">0001367920</ix:nonNumeric><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt:booleanfalse" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF80L2ZyYWc6YmVkNjBlNDI1OTJhNDlhYWExNzk5ODBiMWExYmUzMTMvdGFibGU6NWFjMTFkOThhOGE4NGE5NDg2NWM4YWY1M2E5Y2ZiNGEvdGFibGVyYW5nZTo1YWMxMWQ5OGE4YTg0YTk0ODY1YzhhZjUzYTljZmI0YV8yLTEtMS0xLTA_a3df2dbc-1781-46c1-ab4e-77eadea5c94f">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt:datemonthday" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF80L2ZyYWc6YmVkNjBlNDI1OTJhNDlhYWExNzk5ODBiMWExYmUzMTMvdGFibGU6NWFjMTFkOThhOGE4NGE5NDg2NWM4YWY1M2E5Y2ZiNGEvdGFibGVyYW5nZTo1YWMxMWQ5OGE4YTg0YTk0ODY1YzhhZjUzYTljZmI0YV8zLTEtMS0xLTgy_67377682-a0da-4a92-8829-7ccae5f60ea5">12-31</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cnce-20201210.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001367920</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-10</xbrli:startDate><xbrli:endDate>2020-12-10</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i3b46eabfca754a9a9d85cb2631f02e98_1"></div><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">_________________________________</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGV4dHJlZ2lvbjpkZDAyMzQ0NjkyOGM0YTcyOTdiNTliNTYwOTI4ZWZhMV8yODQw_1dccc211-9ad1-4830-82ae-88df3c1602d3">8-K</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">_________________________________</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported): <ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGV4dHJlZ2lvbjpkZDAyMzQ0NjkyOGM0YTcyOTdiNTliNTYwOTI4ZWZhMV8yOTA_b3a5a85f-7569-4e72-9951-2665a174b87a">December 10, 2020</ix:nonNumeric></span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGV4dHJlZ2lvbjpkZDAyMzQ0NjkyOGM0YTcyOTdiNTliNTYwOTI4ZWZhMV8yODMy_86442096-0dbc-4bf4-b6f8-37fbdba55f5e">Concert Pharmaceuticals, Inc.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in charter)</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.959%"><tr><td style="width:1.0%"></td><td style="width:32.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.146%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.993%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.343%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.155%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6NTg3NDBhNDY1NzNhNDgwZGE5OTMyYWE0NjUwYmUyYzMvdGFibGVyYW5nZTo1ODc0MGE0NjU3M2E0ODBkYTk5MzJhYTQ2NTBiZTJjM18xLTAtMS0xLTA_37761368-379f-4f4e-8010-6b76d81e725a">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6NTg3NDBhNDY1NzNhNDgwZGE5OTMyYWE0NjUwYmUyYzMvdGFibGVyYW5nZTo1ODc0MGE0NjU3M2E0ODBkYTk5MzJhYTQ2NTBiZTJjM18xLTItMS0xLTA_4d3d13b3-ffc2-43fb-99b2-c50f9224887a">001-36310</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6NTg3NDBhNDY1NzNhNDgwZGE5OTMyYWE0NjUwYmUyYzMvdGFibGVyYW5nZTo1ODc0MGE0NjU3M2E0ODBkYTk5MzJhYTQ2NTBiZTJjM18xLTQtMS0xLTA_b8ce3769-f66e-469f-8bed-570f87511f4c">20-4839882</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(State or Other Jurisdiction<br/>of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(Commission<br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">(IRS Employer<br/>Identification No.)</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6MzE4ODczMTQxYTg1NDZjNWE3MWRkOTMyMDEyYjg3YzgvdGFibGVyYW5nZTozMTg4NzMxNDFhODU0NmM1YTcxZGQ5MzIwMTJiODdjOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjozN2E0NjZiNjU3NmQ0NzgwOGEyMWUxZjU0YmQzM2ZhZV85_7585a7cf-1344-406c-af32-1f728d8832fa">65 Hayden Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6MzE4ODczMTQxYTg1NDZjNWE3MWRkOTMyMDEyYjg3YzgvdGFibGVyYW5nZTozMTg4NzMxNDFhODU0NmM1YTcxZGQ5MzIwMTJiODdjOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjozN2E0NjZiNjU3NmQ0NzgwOGEyMWUxZjU0YmQzM2ZhZV8xMw_9185e5ff-0655-43d5-bce4-b30b047edaf6">Suite 3000N</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6MzE4ODczMTQxYTg1NDZjNWE3MWRkOTMyMDEyYjg3YzgvdGFibGVyYW5nZTozMTg4NzMxNDFhODU0NmM1YTcxZGQ5MzIwMTJiODdjOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjozN2E0NjZiNjU3NmQ0NzgwOGEyMWUxZjU0YmQzM2ZhZV8xNg_eb3d7f4f-589f-42bb-a81f-4adb33904125">Lexington</ix:nonNumeric>, <ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6MzE4ODczMTQxYTg1NDZjNWE3MWRkOTMyMDEyYjg3YzgvdGFibGVyYW5nZTozMTg4NzMxNDFhODU0NmM1YTcxZGQ5MzIwMTJiODdjOF8wLTAtMS0xLTAvdGV4dHJlZ2lvbjozN2E0NjZiNjU3NmQ0NzgwOGEyMWUxZjU0YmQzM2ZhZV8yMA_8d855bcb-e359-42f4-a2c6-ac8f856004b5">Massachusetts</ix:nonNumeric>   </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;<ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6MzE4ODczMTQxYTg1NDZjNWE3MWRkOTMyMDEyYjg3YzgvdGFibGVyYW5nZTozMTg4NzMxNDFhODU0NmM1YTcxZGQ5MzIwMTJiODdjOF8wLTEtMS0xLTA_c6db26c3-8358-482b-9b2a-0a431e9efe7f">02421</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#160;(Zip Code)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGV4dHJlZ2lvbjpkZDAyMzQ0NjkyOGM0YTcyOTdiNTliNTYwOTI4ZWZhMV8yODQ1_8b6fb020-4fe7-4c98-b5a2-cb0b4b382211">781</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGV4dHJlZ2lvbjpkZDAyMzQ0NjkyOGM0YTcyOTdiNTliNTYwOTI4ZWZhMV8yODQy_f43fe735-4054-47b3-9fea-d8bfb4f82bbc">860-0045</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former Name or Former Address, if Changed Since Last Report)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;General Instruction A.2. below):</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGV4dHJlZ2lvbjpkZDAyMzQ0NjkyOGM0YTcyOTdiNTliNTYwOTI4ZWZhMV8yODQx_feb5aa4a-121a-447e-b340-b487e405fec9">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGV4dHJlZ2lvbjpkZDAyMzQ0NjkyOGM0YTcyOTdiNTliNTYwOTI4ZWZhMV8yODM1_6e20ff57-5d86-40c9-9e21-e071a9be8039">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGV4dHJlZ2lvbjpkZDAyMzQ0NjkyOGM0YTcyOTdiNTliNTYwOTI4ZWZhMV8yODM2_b45200c8-dd2c-4459-8f37-97d5ed9580cf">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGV4dHJlZ2lvbjpkZDAyMzQ0NjkyOGM0YTcyOTdiNTliNTYwOTI4ZWZhMV8yODMw_f17edb29-dfcf-47ea-aeef-d12b08dfc1f4">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:34.439%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:36.743%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6ZjBhMjRjYjRhMDE0NDE3YzlkMmRlZjRkZDUwZDAzNjgvdGFibGVyYW5nZTpmMGEyNGNiNGEwMTQ0MTdjOWQyZGVmNGRkNTBkMDM2OF8xLTAtMS0xLTA_3e0ed6d9-443b-452b-adf8-becae127e856">Common stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6ZjBhMjRjYjRhMDE0NDE3YzlkMmRlZjRkZDUwZDAzNjgvdGFibGVyYW5nZTpmMGEyNGNiNGEwMTQ0MTdjOWQyZGVmNGRkNTBkMDM2OF8xLTEtMS0xLTA_77bf8784-69bf-4442-8006-362d3053cd89">CNCE</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGFibGU6ZjBhMjRjYjRhMDE0NDE3YzlkMmRlZjRkZDUwZDAzNjgvdGFibGVyYW5nZTpmMGEyNGNiNGEwMTQ0MTdjOWQyZGVmNGRkNTBkMDM2OF8xLTItMS0xLTA_f6d90da7-911a-4db9-b7e6-90a826e725ba">Nasdaq Global Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2). </span></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Emerging growth company </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia3d4ac664db34d89b0d7473fd20acb6c_D20201210-20201210" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjNiNDZlYWJmY2E3NTRhOWE5ZDg1Y2IyNjMxZjAyZTk4L3NlYzozYjQ2ZWFiZmNhNzU0YTlhOWQ4NWNiMjYzMWYwMmU5OF8xL2ZyYWc6ZGQwMjM0NDY5MjhjNGE3Mjk3YjU5YjU2MDkyOGVmYTEvdGV4dHJlZ2lvbjpkZDAyMzQ0NjkyOGM0YTcyOTdiNTliNTYwOTI4ZWZhMV8yODM0_b0750c97-89fd-4d39-a1f0-cfd43009700a">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#168;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On December 10, 2020, the Board of Directors (the &#8220;Board&#8221;) of Concert Pharmaceuticals, Inc. (the &#8220;Company&#8221;) adopted an amendment (the &#8220;By-law Amendment&#8221;) to the Company&#8217;s Amended and Restated By-laws, as amended, amending and restating Article V, Section 5.9 thereof to designate the federal district courts of the United States as the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended.  The Board approved the By-law Amendment to reduce any potential expenses that the Company may incur in connection with any potential actions asserting a claim under the Securities Act of 1933, as amended, if required to defend them in multiple jurisdictions and/or in parallel proceedings in federal and state courts simultaneously.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The foregoing summary and description of the provisions of the By-law Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the By-law Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div style="margin-top:15pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)  Exhibits</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:91.081%"><tr><td style="width:1.0%"></td><td style="width:17.038%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:80.762%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline">Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline" href="restatedby-laws.htm">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%;text-decoration:underline" href="restatedby-laws.htm">Second Amendment to Amended and Restated By-laws</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SIGNATURE</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.303%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.139%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.724%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.277%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CONCERT PHARMACEUTICALS, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td><td colspan="6" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date: December 11, 2020</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">/s/ Jeffrey A. Munsie</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Jeffrey A. Munsie</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Chief Legal Officer</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
[{"type": "8-K", "sequence": "1", "filename": "cnce-20201210.htm", "description": "8-K", "secsgml_size_bytes": 37148}]
{"company-data": {"conformed-name": "CONCERT PHARMACEUTICALS, INC.", "cik": "0001367920", "assigned-sic": "2834", "irs-number": "000000000", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-36310", "film-number": "201383617"}, "business-address": {"street1": "65 HAYDEN AVENUE", "street2": "SUITE 3000N", "city": "LEXINGTON", "state": "MA", "zip": "02421", "phone": "781-860-0045"}, "mail-address": {"street1": "65 HAYDEN AVENUE", "street2": "SUITE 3000N", "city": "LEXINGTON", "state": "MA", "zip": "02421"}, "former-company": {"former-conformed-name": "CONCERT PHARMACEUTICALS INC", "date-changed": "20060628"}}
cnce-20201210
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________
FORM
8-K
_________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
December 10, 2020
Concert Pharmaceuticals, Inc.
(Exact name of registrant as specified in charter)
Delaware
001-36310
20-4839882
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
65 Hayden Avenue
,
Suite 3000N
Lexington
,
Massachusetts
02421
(Address of principal executive offices)
(Zip Code)
Registrant's telephone number, including area code: (
781
)
860-0045
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common stock, $0.001 par value per share
CNCE
Nasdaq Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
¨
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
On December 10, 2020, the Board of Directors (the "Board") of Concert Pharmaceuticals, Inc. (the "Company") adopted an amendment (the "By-law Amendment") to the Company's Amended and Restated By-laws, as amended, amending and restating Article V, Section 5.9 thereof to designate the federal district courts of the United States as the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act of 1933, as amended.  The Board approved the By-law Amendment to reduce any potential expenses that the Company may incur in connection with any potential actions asserting a claim under the Securities Act of 1933, as amended, if required to defend them in multiple jurisdictions and/or in parallel proceedings in federal and state courts simultaneously.
The foregoing summary and description of the provisions of the By-law Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the By-law Amendment, a copy of which is filed as Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d)  Exhibits
Exhibit No.
Description
3.1
Second Amendment to Amended and Restated By-laws
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
CONCERT PHARMACEUTICALS, INC.
Date: December 11, 2020
By:
/s/ Jeffrey A. Munsie
Jeffrey A. Munsie
Chief Legal Officer